Indrayani Biotech Limited (IBL) was incorporated in 1992. The Company came out with a Public Issue in 1994 to part-finance its project to produce cut flowers, strawberries, tissue culture plantlets and hybrid vegetable seeds. IBL is having business operations in the field of Food and Hospitality, Dairy, Healthcare & Pharma, Engineering, Biotech, Agriculture and Infrastructure. The following business units are directly under the management of the company: A Diet Hospitality service (Food and Hospitality sector), Biotech Products and services (Biotech Sector) and Helios Solutions (Power electronics Sector).
IBL started exporting flowers to Holland and Dubai during 1994-95. Restricted water supply and changes in ecology resulted in a shortfall in achieving its goals.
In 1995-96, the company incurred losses due to reasons beyond the control of the management like insufficient water supply, labour problem and sub-standard infrastructure. To overcome the above problems, the company is considering to shift its green houses to alternate locations.
During the year 2010-11, the Scheme of Arrangement, seeking to reduce the equity share capital of the Company by 88%, conversion of unsecured loan into the equity shares, demerging the entire business into Indrayani Tissue Culture Pvt. Ltd., merging YoGoYo Division of Websource Technologies Ltd., was effective from August 21, 2010. Similarly, the Scheme of Arrangement for Amalgamation of Helios Solutions Limited and A-Diet Express Hospitality Services Limited as a going concern with the Company was made effective from April 1, 2018.
IBL Investments Ltd was incorporated as wholly owned subsidiary company in 2022-23; Dindigul Farm Product Pvt Ltd became subsidiary in 2022-23.
Indrayani Biotech share price as on 22 Mar 2026 is Rs. 7.9. Over the past 6 months, the Indrayani Biotech share price has decreased by 30.15% and in the last one year, it has decreased by 55.67%. The 52-week low for Indrayani Biotech share price was Rs. 6.1 and 52-week high was Rs. 20.4.
Indrayani Biotech Limited (IBL) was incorporated in 1992. The Company came out with a Public Issue in 1994 to part-finance its project to produce cut flowers, strawberries, tissue culture plantlets and hybrid vegetable seeds. IBL is having business operations in the field of Food and Hospitality, Dairy, Healthcare & Pharma, Engineering, Biotech, Agriculture and Infrastructure. The following business units are directly under the management of the company: A Diet Hospitality service (Food and Hospitality sector), Biotech Products and services (Biotech Sector) and Helios Solutions (Power electronics Sector).
IBL started exporting flowers to Holland and Dubai during 1994-95. Restricted water supply and changes in ecology resulted in a shortfall in achieving its goals.
In 1995-96, the company incurred losses due to reasons beyond the control of the management like insufficient water supply, labour problem and sub-standard infrastructure. To overcome the above problems, the company is considering to shift its green houses to alternate locations.
During the year 2010-11, the Scheme of Arrangement, seeking to reduce the equity share capital of the Company by 88%, conversion of unsecured loan into the equity shares, demerging the entire business into Indrayani Tissue Culture Pvt. Ltd., merging YoGoYo Division of Websource Technologies Ltd., was effective from August 21, 2010. Similarly, the Scheme of Arrangement for Amalgamation of Helios Solutions Limited and A-Diet Express Hospitality Services Limited as a going concern with the Company was made effective from April 1, 2018.
IBL Investments Ltd was incorporated as wholly owned subsidiary company in 2022-23; Dindigul Farm Product Pvt Ltd became subsidiary in 2022-23.
Indrayani Biotech share price as on 22 Mar 2026 is Rs. 7.9. Over the past 6 months, the Indrayani Biotech share price has decreased by 30.15% and in the last one year, it has decreased by 55.67%. The 52-week low for Indrayani Biotech share price was Rs. 6.1 and 52-week high was Rs. 20.4.
